Man Group’s Harmony Biosciences HRMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.98M | Buy |
252,619
+65,252
| +35% | +$2.06M | 0.02% | 736 |
|
|
2025
Q1 | $6.22M | Sell |
187,367
-26,746
| -12% | -$888K | 0.02% | 788 |
|
|
2024
Q4 | $7.37M | Buy |
214,113
+58,642
| +38% | +$2.02M | 0.02% | 737 |
|
|
2024
Q3 | $6.22M | Sell |
155,471
-2,127
| -1% | -$85.1K | 0.02% | 837 |
|
|
2024
Q2 | $4.75M | Buy |
157,598
+13,039
| +9% | +$393K | 0.01% | 939 |
|
|
2024
Q1 | $4.85M | Buy |
144,559
+5,215
| +4% | +$175K | 0.01% | 934 |
|
|
2023
Q4 | $4.5M | Buy |
+139,344
| New | +$4.5M | 0.01% | 923 |
|
|
2023
Q3 | – | Sell |
-318,899
| Closed | -$11.2M | – | 1021 |
|
|
2023
Q2 | $11.2M | Buy |
+318,899
| New | +$11.2M | 0.03% | 584 |
|
|
2023
Q1 | – | Sell |
-237,002
| Closed | -$13.1M | – | 798 |
|
|
2022
Q4 | $13.1M | Sell |
237,002
-32,622
| -12% | -$1.8M | 0.05% | 466 |
|
|
2022
Q3 | $11.9M | Buy |
+269,624
| New | +$11.9M | 0.06% | 417 |
|
|
2022
Q2 | – | Sell |
-117,970
| Closed | -$5.74M | – | 471 |
|
|
2022
Q1 | $5.74M | Buy |
117,970
+101,329
| +609% | +$4.93M | 0.02% | 829 |
|
|
2021
Q4 | $710K | Buy |
16,641
+10,411
| +167% | +$444K | ﹤0.01% | 1417 |
|
|
2021
Q3 | $239K | Buy |
+6,230
| New | +$239K | ﹤0.01% | 1691 |
|